Leger, FR
Alexandre Leger, Gourdon FR
Patent application number | Description | Published |
---|---|---|
20110030504 | TORQUE-TRANSMITTING DEVICE COMPRISING AN OIL RECUPERATOR WIPER - A torque-transmitting device including a casing inside which a gearwheel is mounted such that it can move by means of at least one rolling bearing housed in a side wall of the casing, the bottom of the casing being shaped to form an oil reserve in which part of the wheel is intended to be immersed, the casing additionally including an oil recuperator wiper arranged in the side wall housing the rolling bearing, above the latter. The oil recuperator wiper includes removable means of attachment to the casing, these means of attachment being accessible from outside the casing. | 02-10-2011 |
Bastien Thesards Leger, Charleville-Mezieres FR
Patent application number | Description | Published |
---|---|---|
20100191027 | METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK - The object of this invention is a suspension of metal nanoparticles with a mean size of between 1 and 20 nanometers, in at least one non-aqueous ionic liquid, whereby said suspension also contains at least one nitrogen-containing ligand, in which said metal nanoparticles comprise at least one transition metal in the zero valence state that is selected from among rhodium, ruthenium, iridium, nickel, and platinum by themselves or in a mixture and in which said nitrogen-containing ligand is selected from the group that is formed by the linear compounds that comprise at least one nitrogen atom, whereby the non-aromatic cyclic compounds comprise at least one nitrogen atom, the non-condensed aromatic compounds comprise at least one nitrogen atom, the condensed aromatic compounds comprise at least one group of two aromatic cycles that are condensed two by two, and at least one nitrogen atom, whereby the condensed aromatic compounds comprise at least 3 aromatic cycles and 1 nitrogen atom, and whereby the condensed aromatic compounds comprise at least 3 aromatic cycles and at least 2 nitrogen atoms that are located in the same aromatic cycle. | 07-29-2010 |
20100228064 | PROCESS FOR HYDROGENATION OF AN AROMATIC FEEDSTOCK THAT AS CATALYST USES A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID - This invention describes a process for hydrogenation of an aromatic feedstock that as a catalytic composition uses a suspension of metal nanoparticles of a mean size of between 1 and 20 nanometers in at least one non-aqueous ionic liquid, whereby said suspension also contains at least one nitrogen-containing ligand, in which said metal nanoparticles comprise a transition metal in the zero-valence state, whereby the transition metal is selected from the groups 8, 9, 10 and 11 of the periodic table and in which said nitrogen-containing ligand comprises 1 to n nitrogen atoms, whereby n is an integer of between 1 and 20. | 09-09-2010 |
Bastien-Thésards Leger, Charleville-Mezieres FR
Patent application number | Description | Published |
---|---|---|
20100191027 | METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK - The object of this invention is a suspension of metal nanoparticles with a mean size of between 1 and 20 nanometers, in at least one non-aqueous ionic liquid, whereby said suspension also contains at least one nitrogen-containing ligand, in which said metal nanoparticles comprise at least one transition metal in the zero valence state that is selected from among rhodium, ruthenium, iridium, nickel, and platinum by themselves or in a mixture and in which said nitrogen-containing ligand is selected from the group that is formed by the linear compounds that comprise at least one nitrogen atom, whereby the non-aromatic cyclic compounds comprise at least one nitrogen atom, the non-condensed aromatic compounds comprise at least one nitrogen atom, the condensed aromatic compounds comprise at least one group of two aromatic cycles that are condensed two by two, and at least one nitrogen atom, whereby the condensed aromatic compounds comprise at least 3 aromatic cycles and 1 nitrogen atom, and whereby the condensed aromatic compounds comprise at least 3 aromatic cycles and at least 2 nitrogen atoms that are located in the same aromatic cycle. | 07-29-2010 |
Cédric Leger, Pisa FR
Patent application number | Description | Published |
---|---|---|
20100071669 | INJECTION VALVE - An injection valve ( | 03-25-2010 |
Christophe Leger, Marseille FR
Patent application number | Description | Published |
---|---|---|
20110212502 | [NiFe]-Hydrogenases Having an Improved Resistance to Dioxygen, Process for Obtaining Them and Their Applications - The invention relates to [NiFe]-hydrogenases having an improved resistance to dioxygen, said [NiFe]-hydrogenases may be obtained by:—providing an initial polynucleotide comprising a sequence encoding a large subunit of a [NiFe]-hydrogenase, said large subunit comprising the following peptide motifs: L1: RGXE, wherein X=L, I, F, V or M L2: [R/K]X | 09-01-2011 |
Eric Leger, Chapareillan FR
Patent application number | Description | Published |
---|---|---|
20130099904 | WIRELESS DETECTION DEVICE - The invention relates to a detection device ( | 04-25-2013 |
Georges Leger, Marignier FR
Patent application number | Description | Published |
---|---|---|
20130286797 | EXTENSIBLE CLASP FOR A WRIST STRAP IN PARTICULAR OF A WATCH - The invention relates to a clasp comprising an extensible buckle for a wrist strap making it possible to control the length of the wrist strap. For this purpose, the clasp comprises: a first and a second strip ( | 10-31-2013 |
20140130545 | EXTENDABLE CLASP FOR A BRACELET IN PARTICULAR FOR A WATCH - The present invention concerns a clasp with an extensible buckle for a bracelet enabling the length of the bracelet to be adjusted. This clasp comprises: a central support ( | 05-15-2014 |
Gilles Leger, St Faust FR
Patent application number | Description | Published |
---|---|---|
20140299328 | SUBSEA WELLHEAD ASSEMBLY, A SUBSEA INSTALLATION USING SAID WELLHEAD ASSEMBLY, AND A METHOD FOR COMPLETING A WELLHEAD ASSEMBLY - A subsea wellhead assembly comprising a casing housing and a casing extending down inside the well, and a tubing hanger. The tubing hanger comprises first and second valves, each valve being a fail safe valve. | 10-09-2014 |
Hugues Leger, Villeurbanne FR
Patent application number | Description | Published |
---|---|---|
20110257810 | ONBOARD VEHICLE SYSTEM AND METHOD FOR CONFIGURING VEHICLE FUNCTIONALITIES - An onboard vehicle control system includes a vehicle electronic control adapted to control at least one vehicle functionality, a human machine interface communicating with the vehicle electronic control and including a human input interface. The vehicle electronic control includes a preloaded configuration program for configuring the vehicle functionality and the vehicle electronic control is adapted to, upon manual entry of an activation code by a user with the human input interface, execute the preloaded configuration program which modifies the vehicle functionality settings. | 10-20-2011 |
Jean-Michel Leger, Villard Bonnot FR
Patent application number | Description | Published |
---|---|---|
20100244970 | ATOMIC CLOCK REGULATED BY A STATIC FIELD AND TWO OSCILLATING FIELDS - An atomic clock including a mechanism applying both a static magnetic field and two oscillating magnetic fields, all mutually perpendicular, in a magnetic shield. The amplitudes and frequencies of the oscillating magnetic fields may be chosen so as to annihilate energy variations between sub-transition levels of excited atoms and to reinforce a clock output signal, and with low sensitivity to defects in regulation. | 09-30-2010 |
20100259256 | APPARATUS WITH AMBIENT MAGNETIC FIELD CORRECTION - This atomic clock comprises means for applying two mutually perpendicular oscillating magnetic fields ( | 10-14-2010 |
20100315173 | ATOMIC CLOCK OPERATING WITH HELIUM 3 - An atomic clock comprises helium 3 plasma as measurement medium, which is taken to the plasma state to exploit the metastable state of the material and the levels of the hyperfine structure, the lifetime of which is long and which thus enable an easier measurement than the excitations of gaseous atoms. | 12-16-2010 |
20120062221 | METHOD OF CALIBRATING AN ATOMIC-FUNCTIONING APPARATUS - This method makes it possible to carry out the auto-calibration of the electromagnetic coils ( | 03-15-2012 |
20130002245 | HIGH RESOLUTION AND HIGH PRECISION VECTOR MAGNETOMETER - The present invention relates to a vector magnetometer for measuring the components of an ambient magnetic field. This vector magnetometer comprises an optically pumped scalar magnetometer ( | 01-03-2013 |
20140109372 | METHOD FOR MANUFACTURING AN OPTICAL FIBRE LASER - The laser comprising an optical fibre having two ends of which a first whereby the light is to be received, and a doped section for absorbing at least part of the light received via the first end and emitting light, the method includes: applying a torsion angle to the optical fibre; supplying light having a pump power at the first end of the optical fibre; checking that the Polarisation Extinction Ratio of the light output from the first end of the optical fibre remains greater than a predetermined value throughout a predetermined range of the pump power; and, if the Polarisation Extinction Ratio remains greater than the predetermined value throughout the predetermined range of the pump power, attaching the optical fibre to a mechanical mount at two attachment points of the optical fibre situated on either side of the doped section, with the torsion angle applied to the optical fibre. | 04-24-2014 |
20140368193 | ISOTROPIC AND INTEGRATED OPTICAL PUMPING MAGNETOMETER - A magnetic resonance optical pumping isotropic magnetometer including a laser, a gas filled cell, a HF discharge circuit, RF magnetic field generating coils surrounding the cell, a first frequency regulating mechanism of an RF generator, a second polarization regulating mechanism of the laser beam, and a third regulating mechanism of the direction of the RF magnetic field. The direction of polarization of the laser beam at an inlet of the cell is orthogonally aligned with the magnetic field to be measured by virtue of a liquid crystal polarization rotator. The magnetometer is well-adapted to an integrated arrangement. | 12-18-2014 |
20140368214 | ELECTRIC CABLE WEAR CONTROL SYSTEM - A system including: a cable including: a core capable of transporting at least one useful electric signal; a sheath surrounding said core; at least one conductive wear detection strand embedded in the sheath and substantially extending along the entire length of the cable; and at least one reference conductive element which is not connected to said at least one wear detection strand and substantially extends along the entire cable length; and a control unit capable of measuring the capacitance or the resistance formed between said at least one strand and the reference conductive element. | 12-18-2014 |
Michel Leger, Meudon FR
Patent application number | Description | Published |
---|---|---|
20150127543 | ELECTRONIC TRANSACTION SYSTEM AND A TRANSACTION TERMINAL ADAPTED FOR SUCH A SYSTEM - A system for performing electronic transaction includes: a payment terminal including a human interface module, a first processor, and an internal bus for connecting these elements; a host terminal connectable to the human interface module through a connection; and a security module. The human interface module includes a keyboard, a display, a card reader for reading and authenticating a bank card or credit card. The host terminal includes a second processor, a memory, and a power supply. A transaction terminal task manager is included in the first security module, the first security module being hosted in the host terminal. The human interface module executes transaction phases under control of the security module, and executes security treatments, totally autonomously from the host terminal. The security treatments include presentation of a PIN code to the bank card or credit card. | 05-07-2015 |
Michel Leger, Rueil-Malmaison FR
Patent application number | Description | Published |
---|---|---|
20110251797 | METHOD OF MONITORING A GEOLOGICAL GAS STORAGE SITE BY STRATIGRAPHIC INVERSION OF SEISMIC DATA - A method of monitoring an underground formation into which a gas is injected or from which a gas is produced, by a stratigraphic inversion of seismic data with anamorphosis of impedances. Pre-injection and post-injection seismic data are acquired. A pre-injection seismic impedance cube IP | 10-13-2011 |
Michel Leger, Saint Germain En Laye FR
Patent application number | Description | Published |
---|---|---|
20140351739 | METHOD FOR GENERATING AT LEAST ONE PART OF A VIRTUAL KEYPAD, CORRESPONDING ELECTRONIC TERMINAL AND COMPUTER PROGRAM PRODUCT - A method is provided for generating at least one part of a virtual keypad on a touch screen of an electronic terminal. The method includes, prior to displaying the virtual keypad on the touch screen, computing a random graphic representation of the virtual keypad delivering at least one parameter representing a random zone of occupancy of the virtual keypad on the touch screen. | 11-27-2014 |
20150019433 | METHOD FOR CARRYING OUT A TRANSACTION, CORRESPONDING TERMINAL AND COMPUTER PROGRAM - A method is provided for carrying out a financial transaction. The method is implemented within a terminal of a user wishing to carry out a transaction with a merchant. The method includes: receiving a merchant's identifier; receiving a piece of data representing a transaction amount; generating a transaction by using the user's terminal to the benefit of the merchant; and transmitting the transaction to a transaction management server. | 01-15-2015 |
Olivier Leger, Annemasse FR
Patent application number | Description | Published |
---|---|---|
20080286198 | Novel anti-IGF-IR antibodies and uses thereof - The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor IGF-IR and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR receptor, especially monoclonal antibodies of murine, chimeric and humanized origin, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR receptor. The invention finally comprises products and/or compositions comprising such antibodies in combination with anti-EGFR antibodies and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers. | 11-20-2008 |
20110014122 | NOVEL ANTI-IGF-IR AND/OR ANTI-INSULIN/IGF-I HYBRID RECEPTORS ANTIBODIES AND USES THEREOF - The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor (IGF-IR) and/or the insulin/IGF-I hybrid receptor (hybrid-R) and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR and/or hybrid-R, especially monoclonal antibodies of murine, chimeric and humanized origin, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR and/or hybrid-R or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR and/or hybrid-R. The invention finally comprises products and/or compositions comprising such antibodies in combination with anti-EGFR antibodies and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers. | 01-20-2011 |
20110183376 | NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF - The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor IGF-IR and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR receptor, especially monoclonal antibodies of murine, chimeric and humanized origin, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR receptor. The invention finally comprises products and/or compositions comprising such antibodies in combination with anti-EGFR antibodies and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers. | 07-28-2011 |
20120208721 | NOVEL ANTI-IGF-IR AND/OR ANTI-INSULIN/IGF-I HYBRID RECEPTORS ANTIBODIES AND USES THEREOF - The present invention relates to methods of identifying IGF-IR modulators and hybrid-R modulators comprising contacting IGF-IR with a humanized anti-IGF-IR antibody and contacting hybrid-R with a humanized anti-hybrid-R antibody, respectively. | 08-16-2012 |
Olivier Leger, Saint-Sixt FR
Patent application number | Description | Published |
---|---|---|
20140023641 | ANTIBODY WITH SPECIFICITY FOR GM-CSF (I) - The present invention relates to antibodies with specificity for granulocyte-macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases. | 01-23-2014 |
20140065163 | ANTIBODY WITH SPECIFICITY FOR GM-CSF (II) - The present invention relates to antibodies with specificity for granulocyte-macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases. | 03-06-2014 |
20140314743 | AMINO ACID SEQUENCES DIRECTED AGAINST IL-17A, IL-17F AND/OR IL17-A/F AND POLYPEPTIDES COMPRISING THE SAME - The present disclosure relates to amino acid sequences that are directed against (as defined herein) any of IL-17A, IL-17F and/or IL-17A/F including combinations thereof, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. | 10-23-2014 |
20140341917 | ANTI-PD-L1 ANTIBODIES AND USES THEREOF - The present application relates to anti-PD-L1 antibodies or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, for the treatment of and cancer. | 11-20-2014 |
Olivier Leger, Boulogne-Billancourt FR
Patent application number | Description | Published |
---|---|---|
20130273031 | NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF - The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor IGF-IR and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR receptor, especially monoclonal antibodies of murine, chimeric and humanized origin, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR receptor. The invention finally comprises products and/or compositions comprising such antibodies in combination with anti-EGFR antibodies and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers. | 10-17-2013 |
20150079080 | NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF - The present invention relates to novel antibodies capable of binding specifically to the human insulin-like growth factor I receptor IGF-IR and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR receptor, especially monoclonal antibodies of murine, chimeric and humanized origin, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of these antibodies as a medicament for the prophylactic and/or therapeutic treatment of cancers overexpressing IGF-IR or any pathology connected with the overexpression of said receptor as well as in processes or kits for diagnosis of illnesses connected with the overexpression of the IGF-IR receptor. The invention finally comprises products and/or compositions comprising such antibodies in combination with anti-EGFR antibodies and/or compounds and/or anti-cancer agents or agents conjugated with toxins and their use for the prevention and/or the treatment of certain cancers. | 03-19-2015 |
Pascal Leger, Gisors FR
Patent application number | Description | Published |
---|---|---|
20140253405 | ANTENNA OF INVERTED F ANTENNA TYPE INTEGRATED INTO A PRINTED CARD, AND SYSTEM - An IFA type antenna is integrated into a printed card, the printed card having a main-extension plane. The IFA type antenna has a first electrically conducting element, serving as earth plane, a second electrically conducting element, serving as radiating element of the antenna, an electrically conducting connection, serving to short-circuit the first electrically conducting element and the second electrically conducting element, and an excitation element being in electrical contact with the second electrically conducting element. The second electrically conducting element has a first part, a second part and a third part in various planes of the printed card. | 09-11-2014 |
Patrick Leger, Saint Didier Au Mont D'Or FR
Patent application number | Description | Published |
---|---|---|
20110034819 | DEVICE FOR DETECTING THE OBSERVANCE BY A PATIENT OF AN OXYGEN-THERAPY TREATMENT - The invention relates to a device for implementing a system for detecting the observance by a patient of an oxygen-therapy treatment involving an oxygen supply, and for recording the data of said treatment and transmitting said data. The invention also relates to the use of said device, and to a method for tracking the observance of an oxygen-therapy treatment. | 02-10-2011 |
Sandrine Leger, Anglet FR
Patent application number | Description | Published |
---|---|---|
20090258346 | Method of selecting sunflower genotypes with high oleic acid content in seed oil - The present invention relates to the selection of sunflower genotypes with high oleic acid content in seed oil. The invention concerns more particularly molecular markers useful for a rapid and easy selection of sunflower lines and then sunflower hybrids capable of producing seeds having high oleic acid content. | 10-15-2009 |
Vincent Leger, Aix En Provence FR
Patent application number | Description | Published |
---|---|---|
20080282547 | Knife with a Retracting Blade, Usable in Particular in a Hostile Environment - A knife includes a sheath ( | 11-20-2008 |